1
|
Damasceno AM, Kesley R, Valadão M, Braga F, D'Almeida CA, Pitombo MB. Preoperative management in octogenarian patients with rectal cancer. Heliyon 2025; 11:e41469. [PMID: 39834413 PMCID: PMC11742831 DOI: 10.1016/j.heliyon.2024.e41469] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2024] [Revised: 12/09/2024] [Accepted: 12/23/2024] [Indexed: 01/22/2025] Open
Abstract
Background In recent years, the rise in average lifespan has been linked to an increase in the occurrence of diseases associated with aging worldwide. Rectal tumors often occur in elderly patients. Methods Between January and August 2024, 6 experts in colorectal cancer met to develop an algorithm to organize the interdisciplinary and multimodal preoperative approaches in the octogenarian population with rectal cancer. To develop the algorithm, we conducted a straightforward search within the PubMed database and also reviewed the citations of the most pertinent articles we discovered. The quality of the methods used in the final selection of 76 sources was evaluated, every single source was scrutinized and analyzed, and a team of six experts created an algorithm. Results An algorithm for preoperative management of octogenarian patients with rectal cancer was created to encapsulate essential information and provide a contemporary resource for physicians, surgeons, physiotherapists, and nutritionists to utilize in optimal clinical practice. Conclusions Octogenarian patients with rectal cancer are special-character groups and require specific preoperative management to better the surgical outcome.
Collapse
Affiliation(s)
- Arthur M. Damasceno
- Post-Graduate Program in Medical Sciences, Rio de Janeiro State University (UERJ), 444 Prof Manuel de Abreu Avenue, Rio de Janeiro, RJ, 20550-170, Brazil
| | - Rubens Kesley
- Abdominal Surgery Department and Nutritional and Dietetic Service, Brazil National Cancer Institute (INCA), 23 Praça da Cruz Vermelha, Rio de Janeiro, RJ, 20230-130, Brazil
| | - Marcus Valadão
- Abdominal Surgery Department and Nutritional and Dietetic Service, Brazil National Cancer Institute (INCA), 23 Praça da Cruz Vermelha, Rio de Janeiro, RJ, 20230-130, Brazil
| | - Fabrício Braga
- Laboratório de Performance Humana, 1 Largo do Ibam, Rio de Janeiro, RJ, 22271-070, Brazil
| | - Cristiane A. D'Almeida
- Abdominal Surgery Department and Nutritional and Dietetic Service, Brazil National Cancer Institute (INCA), 23 Praça da Cruz Vermelha, Rio de Janeiro, RJ, 20230-130, Brazil
| | - Marcos B. Pitombo
- Post-Graduate Program in Medical Sciences, Rio de Janeiro State University (UERJ), 444 Prof Manuel de Abreu Avenue, Rio de Janeiro, RJ, 20550-170, Brazil
| |
Collapse
|
2
|
Hamaker ME, Wildiers H, Ardito V, Arsandaux J, Barthod-Malat A, Davies P, Degol L, Ferrara L, Fourrier C, Kenis C, Kret M, Lalet C, Pelissier SM, O'Hanlon S, Rostoft S, Seghers N, Saillour-Glénisson F, Staines A, Schwimmer C, Thevenet V, Wallet C, Soubeyran P. Study protocol for two stepped-wedge interventional trials evaluating the effects of holistic information technology-based patient-oriented management in older multimorbid patients with cancer: The GERONTE trials. J Geriatr Oncol 2024; 15:101761. [PMID: 38581958 DOI: 10.1016/j.jgo.2024.101761] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2024] [Revised: 03/07/2024] [Accepted: 03/26/2024] [Indexed: 04/08/2024]
Abstract
INTRODUCTION Current hospital-based care pathways are generally single-disease centred. As a result, coexisting morbidities are often suboptimally evaluated and managed, a deficiency becoming increasingly apparent among older patients who exhibit heterogeneity in health status, functional abilities, frailty, and other geriatric impairments. To address this issue, our study aims to assess a newly developed patient-centred care pathway for older patients with multimorbidity and cancer. The new care pathway was based on currently available evidence and co-designed by end-users including health care professionals, patients, and informal caregivers. Within this care pathway, all healthcare professionals involved in the care of older patients with multimorbidity and cancer will form a Health Professional Consortium (HPC). The role of the HPC will be to centralise oncologic and non-oncologic treatment recommendations in accordance with the patient's priorities. Moreover, an Advanced Practice Nurse will act as case-manager by being the primary point of contact for the patient, thus improving coordination between specialists, and by organising and leading the consortium. Patient monitoring and the HPC collaboration will be facilitated by digital communication tools designed specifically for this purpose, with the added benefit of being customisable for each patient. MATERIALS AND METHODS The GERONTE study is a prospective international, multicentric study consisting of two stepped-wedge trials performed at 16 clinical sites across three European countries. Each trial will include 720 patients aged 70 years and over with a new or progressive cancer (breast, lung, colorectal, prostate) and at least one moderate or severe multimorbidity. The patients in the intervention group will receive the new care pathway whereas patients in the control group will receive usual oncologic care. DISCUSSION GERONTE will evaluate whether this kind of holistic, patient-oriented healthcare management can improve quality of life (primary outcome) and other valuable endpoints in older patients with multimorbidity and cancer. An ancillary study will assess in depth the socio-economic impact of the intervention and deliver concrete implementation guidelines for the GERONTE intervention care pathway. TRIAL REGISTRATION FRONE: NCT05720910 TWOBE: NCT05423808.
Collapse
Affiliation(s)
- Marije E Hamaker
- Department of Geriatric Medicine, Diakonessenhuis Utrecht, the Netherlands.
| | - Hans Wildiers
- Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium
| | - Vittoria Ardito
- Department SDA Bocconi, Government, Health and Not for profit Division, CERGAS, Bocconi University, Milan, Italy
| | - Julie Arsandaux
- Nantes Université, Univ Angers, Laboratoire de psychologie des Pays de la Loire, LPPL, UR 4638, F-44000 Nantes, France; Univ. Bordeaux, INSERM, Institut Bergonié, CIC 1401, Euclid/F-CRIN clinical trials platform, F-33000 Bordeaux, France
| | - Aurore Barthod-Malat
- Univ. Bordeaux, INSERM, Institut Bergonié, CIC 1401, Euclid/F-CRIN clinical trials platform, F-33000 Bordeaux, France
| | - Paul Davies
- School of Nursing, Psychotherapy and Community Health, Dublin City University, Glasnevin, Dublin 9, Ireland
| | - Lien Degol
- Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium
| | - Lucia Ferrara
- Department SDA Bocconi, Government, Health and Not for profit Division, CERGAS, Bocconi University, Milan, Italy
| | - Celia Fourrier
- Univ. Bordeaux, INSERM, Institut Bergonié, CIC 1401, Euclid/F-CRIN clinical trials platform, F-33000 Bordeaux, France
| | - Cindy Kenis
- Department of General Medical Oncology and Geriatric Medicine, University Hospitals Leuven, Leuven, Belgium; Department of Public Health and Primary Care, Academic Centre for Nursing and Midwifery, KU Leuven, Leuven, Belgium
| | - Marion Kret
- Univ. Bordeaux, INSERM, Institut Bergonié, CIC 1401, Euclid/F-CRIN clinical trials platform, F-33000 Bordeaux, France; CHU de Bordeaux, INSERM, Institut Bergonié, CIC 1401, Euclid/F-CRIN clinical trials platform, F-33000 Bordeaux, France
| | - Caroline Lalet
- Univ. Bordeaux, INSERM, Institut Bergonié, CIC 1401, Euclid/F-CRIN clinical trials platform, F-33000 Bordeaux, France
| | - Simone Mathoulin Pelissier
- Univ. Bordeaux, INSERM, Institut Bergonié, CIC 1401, Euclid/F-CRIN clinical trials platform, F-33000 Bordeaux, France; Univ Bordeaux, Inserm BordHEalth eaux Population U1219 Epicene Team, France
| | - Shane O'Hanlon
- Department of Geriatric Medicine, St Vincent's University Hospital, D04 T6F4 Dublin, Ireland; Department of Geriatric Medicine, University College Dublin, D04 V1W8 Dublin, Ireland
| | - Siri Rostoft
- Department of Geriatric Medicine, Oslo University Hospital, 0424 Oslo, Norway; Institute of Clinical Medicine, University of Oslo, 0318 Oslo, Norway
| | - Nelleke Seghers
- Department of Geriatric Medicine, Diakonessenhuis Utrecht, the Netherlands
| | - Florence Saillour-Glénisson
- Univ. Bordeaux, INSERM, Institut Bergonié, CIC 1401, Euclid/F-CRIN clinical trials platform, F-33000 Bordeaux, France; CHU de Bordeaux, INSERM, Institut Bergonié, CIC 1401, Euclid/F-CRIN clinical trials platform, F-33000 Bordeaux, France
| | - Anthony Staines
- School of Nursing, Psychotherapy and Community Health, Dublin City University, Glasnevin, Dublin 9, Ireland
| | - Christine Schwimmer
- Univ. Bordeaux, INSERM, Institut Bergonié, CIC 1401, Euclid/F-CRIN clinical trials platform, F-33000 Bordeaux, France; CHU de Bordeaux, INSERM, Institut Bergonié, CIC 1401, Euclid/F-CRIN clinical trials platform, F-33000 Bordeaux, France
| | - Vincent Thevenet
- Univ. Bordeaux, INSERM, Institut Bergonié, CIC 1401, Euclid/F-CRIN clinical trials platform, F-33000 Bordeaux, France
| | - Cedric Wallet
- Univ. Bordeaux, INSERM, Institut Bergonié, CIC 1401, Euclid/F-CRIN clinical trials platform, F-33000 Bordeaux, France; CHU de Bordeaux, INSERM, Institut Bergonié, CIC 1401, Euclid/F-CRIN clinical trials platform, F-33000 Bordeaux, France
| | - Pierre Soubeyran
- Department of Medical Oncology, Institut Bergonié, Inserm U1312, SIRIC BRIO, Université de Bordeaux, 33076 Bordeaux, France
| |
Collapse
|